Regentis Biomaterials Ltd.
RGNT- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001912966
No open-market purchases or sales by Regentis Biomaterials Ltd. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $2.98M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Regentis Biomaterials Ltd. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 0 | 3 | +3 |
| Shares | 0 | 281.0K | +281.0K |
| Value | $0 | $1.89M | +$1.89M |
New holders (3)
Institutions that held Regentis Biomaterials Ltd. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Rosalind Advisors, Inc. | 251,510 | $1.70M | 0.65% |
| Warberg Asset Management LLC | 19,093 | $127.0K | 0.04% |
| Citadel Advisors LLC | 10,412 | $70.2K | 0.00% |
Sold out (0)
Institutions that held Regentis Biomaterials Ltd. at the end of Q3 2025 and filed for Q4 2025 without it.
None.